ATE99925T1 - Verfahren zur herstellung eines ranitidin-harzabsorbates. - Google Patents

Verfahren zur herstellung eines ranitidin-harzabsorbates.

Info

Publication number
ATE99925T1
ATE99925T1 AT90312263T AT90312263T ATE99925T1 AT E99925 T1 ATE99925 T1 AT E99925T1 AT 90312263 T AT90312263 T AT 90312263T AT 90312263 T AT90312263 T AT 90312263T AT E99925 T1 ATE99925 T1 AT E99925T1
Authority
AT
Austria
Prior art keywords
resin
ranitidine
absorbate
preparing
adsorbate
Prior art date
Application number
AT90312263T
Other languages
English (en)
Inventor
Stephen John Douglas
Fiona Ruth Bird
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ATE99925T1 publication Critical patent/ATE99925T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Glass Compositions (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Phenolic Resins Or Amino Resins (AREA)
  • Furan Compounds (AREA)
AT90312263T 1989-11-10 1990-11-09 Verfahren zur herstellung eines ranitidin-harzabsorbates. ATE99925T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898925484A GB8925484D0 (en) 1989-11-10 1989-11-10 Process
EP90312263A EP0431759B1 (de) 1989-11-10 1990-11-09 Verfahren zur Herstellung eines Ranitidin-Harz-Absorbates

Publications (1)

Publication Number Publication Date
ATE99925T1 true ATE99925T1 (de) 1994-01-15

Family

ID=10666117

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90312263T ATE99925T1 (de) 1989-11-10 1990-11-09 Verfahren zur herstellung eines ranitidin-harzabsorbates.

Country Status (9)

Country Link
EP (1) EP0431759B1 (de)
JP (1) JPH03206037A (de)
AT (1) ATE99925T1 (de)
AU (1) AU6652790A (de)
CA (1) CA2029667A1 (de)
DE (1) DE69005993T2 (de)
DK (1) DK0431759T3 (de)
ES (1) ES2047864T3 (de)
GB (1) GB8925484D0 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9104042D0 (en) * 1991-02-26 1991-04-10 Abbott Lab Taste-masked buflomedil preparation
US20020031490A1 (en) * 2000-07-27 2002-03-14 Bellamy Simon Andrew Method for preparing resinates
WO2003061709A1 (en) * 2002-01-18 2003-07-31 Advanced Phytonics Limited A method for preparing resinates
GR1009069B (el) * 2015-01-05 2017-07-07 Λαμδα Φαρμακευτικα Εργαστηρια Εφαρμοσμενης Ερευνας & Αναπτυξης Α.Ε. Ποσιμα διαλυματα υψηλης συγκεντρωσης που περιεχουν υδροχλωρικη ρανιτιδινη

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB838952A (en) * 1957-10-03 1960-06-22 Clinical Products Ltd Resin-drug compounds
FR1335502A (fr) * 1960-06-02 1963-08-23 Merck & Co Inc Nouveaux composés d'adsorption de la nicotinamide
DE2246037B2 (de) * 1972-09-20 1975-02-27 Taeschner & Co, 8831 Kipfenberg Peroral anwendbares Arzneimittel mit verzögerter Resorbierbarkeit in Suspensionsform
GB1462356A (en) * 1973-07-10 1977-01-26 Beecham Group Ltd Pharmaceutical compositions
GB8629781D0 (en) * 1986-12-12 1987-01-21 Glaxo Group Ltd Pharmaceutical compositions
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorbate comprising ranitidine together with a synthetic cation exchange resin, its preparation and pharmaceutical compositions containing it

Also Published As

Publication number Publication date
DE69005993D1 (de) 1994-02-24
GB8925484D0 (en) 1989-12-28
EP0431759A1 (de) 1991-06-12
EP0431759B1 (de) 1994-01-12
DE69005993T2 (de) 1994-05-05
CA2029667A1 (en) 1991-05-11
ES2047864T3 (es) 1994-03-01
DK0431759T3 (da) 1994-02-28
JPH03206037A (ja) 1991-09-09
AU6652790A (en) 1991-05-16

Similar Documents

Publication Publication Date Title
ATE116003T1 (de) Verfahren zur herstellung und reinigung von bernsteinsäure.
ATE24658T1 (de) Verfahren zur herstellung eines molkeproduktes.
ATE122054T1 (de) Verfahren zur herstellung eines intravenös verträglichen immunglobulin-g-präparates.
ATE135577T1 (de) Verwendung von buspiron zur herstellung eines pharmazeutischen präparats zur behandlung der alkoholsucht
DE59005902D1 (de) Verfahren zur Herstellung niederer, mehrwertiger Alkohole.
DE69011859D1 (de) Verwendung von sigma-rezeptor-liganden zur herstellung eines anxiolytikums.
DE68918016D1 (de) Verfahren zur Herstellung eines Dimethyltetralins.
DE69011192D1 (de) Verfahren zur Herstellung eines durchlässigen Klebstoffbandes.
EP0391393A3 (de) Verfahren zur Herstellung von Cefodizim-Dinatrium
DE68902575D1 (de) Verfahren zur herstellung von dihydroxybenzolen.
DE69011880D1 (de) Verfahren zur Herstellung von L-Aminosäuren durch Fermentation.
DE59008170D1 (de) Verfahren zur Herstellung mikronisierter bioabbaubarer Partikel.
DE69016840D1 (de) Verfahren zur Herstellung eines lateralen Bipolartransistors.
DE3788900D1 (de) Verfahren zur Herstellung eines länglichen gesinterten Farmkörpers.
DE69217913D1 (de) Verfahren zur Aromatisierung von Milchschokolade
DE68923260D1 (de) Verfahren zur Herstellung eines Derivates der 3,5,6-Trihydroxyhexansäure.
DE69005993D1 (de) Verfahren zur Herstellung eines Ranitidin-Harz-Absorbates.
DE69009682D1 (de) Verfahren zur Herstellung von Cyclohexanolderivaten.
BG47196A3 (en) Method for preparing of carbonic acids
DE3854266D1 (de) Verfahren zur Modifizierung eines Molekularsiebes.
DE68917709D1 (de) Verfahren zur Herstellung eines Pertussis-Toxin-Toxoides.
DE69008547D1 (de) Verfahren zur Herstellung eines aromatischen Alkohols.
ATE94901T1 (de) Verfahren zur herstellung eines macerierenden aspergillus-enzyms.
ATE101041T1 (de) Verfahren zur herstellung eines stabilen faktors viii.
ATE1012T1 (de) Verfahren zur herstellung von cis-2,6-dimethylmorpholin.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee